Literature DB >> 1776524

Evaluation of brain SPECT in the diagnosis and prognosis of the normal pressure hydrocephalus syndrome.

J M Granado1, F Diaz, R Alday.   

Abstract

From January 1989 to September 1990 fourteen patients with the Normal Pressure Hydrocephalus (NPH) syndrome were diagnosed in our Service. All patients were studied by CT-Scan, Radionuclide Cisternography and brain Single Photon Emission Computed Tomography (SPECT). In this series, the predictive value of the brain SPECT was assessed. A statistically significant relationship between SPECT patterns and clinical outcome was found. The patients who showed a Dementia Alzheimer Type (DAT) pattern on SPECT had worse results. The results are discussed and compared with those reported by other authors.

Entities:  

Mesh：

Year:  1991        PMID： 1776524     DOI： 10.1007/bf01405132

Source DB:  PubMed          Journal:  Acta Neurochir (Wien)        ISSN： 0001-6268            Impact factor:   2.216


  17 in total

Review 1.  Perfusion and receptor SPECT in the dementias--George Taplin memorial lecture.

Authors:  B L Holman
Journal:  J Nucl Med       Date:  1986-06       Impact factor: 10.057

Review 2.  Critical analysis of the use of computer-assisted transverse axial tomography to study human brain in aging and dementia of the Alzheimer type.

Authors:  C DeCarli; J A Kaye; B Horwitz; S I Rapoport
Journal:  Neurology       Date:  1990-06       Impact factor: 9.910

3.  Technetium-99m HM-PAO-SPECT study of regional cerebral perfusion in early Alzheimer's disease.

Authors:  D Perani; V Di Piero; G Vallar; S Cappa; C Messa; G Bottini; A Berti; D Passafiume; G Scarlato; P Gerundini
Journal:  J Nucl Med       Date:  1988-09       Impact factor: 10.057

4.  Surgical treatment of idiopathic hydrocephalus in elderly patients.

Authors:  R C Petersen; B Mokri; E R Laws
Journal:  Neurology       Date:  1985-03       Impact factor: 9.910

Review 5.  CSF shunts for dementia, incontinence, and gait disturbance.

Authors:  P M Black; R G Ojemann; A Tzouras
Journal:  Clin Neurosurg       Date:  1985

6.  A 99Tcm-labelled radiotracer for the investigation of cerebral vascular disease.

Authors:  P J Ell; J M Hocknell; P H Jarritt; I Cullum; D Lui; D Campos-Costa; D P Nowotnik; R D Pickett; L R Canning; R D Neirinckx
Journal:  Nucl Med Commun       Date:  1985-08       Impact factor: 1.690

7.  Iofetamine I 123 single photon emission computed tomography is accurate in the diagnosis of Alzheimer's disease.

Authors:  K A Johnson; B L Holman; T J Rosen; J S Nagel; R J English; J H Growdon
Journal:  Arch Intern Med       Date:  1990-04

8.  Technetium-99m-d, 1-HM-PAO: a new radiopharmaceutical for imaging regional brain perfusion using SPECT--a comparison with iodine-123 HIPDM.

Authors:  J P Leonard; D P Nowotnik; R D Neirinckx
Journal:  J Nucl Med       Date:  1986-12       Impact factor: 10.057

9.  Initial experience with technetium-99m HM-PAO brain SPECT.

Authors:  I Podreka; E Suess; G Goldenberg; M Steiner; T Brücke; C Müller; W Lang; R D Neirinckx; L Deecke
Journal:  J Nucl Med       Date:  1987-11       Impact factor: 10.057

10.  Comparison of technetium-99m aminoalkyl diaminodithiol (DADT) analogs as potential brain blood flow imaging agents.

Authors:  U Scheffel; H W Goldfarb; S Z Lever; R L Gungon; H D Burns; H N Wagner
Journal:  J Nucl Med       Date:  1988-01       Impact factor: 10.057
View more
  1 in total

1.  Heterogeneous cerebral glucose metabolism in normal pressure hydrocephalus.

Authors:  E Tedeschi; S G Hasselbalch; G Waldemar; M Juhler; P Høgh; S Holm; L Garde; L L Knudsen; L Klinken; F Gjerris
Journal:  J Neurol Neurosurg Psychiatry       Date:  1995-12       Impact factor: 10.154
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.